On Tuesday, Voyager Therapeutics Inc (NASDAQ: VYGR) was -10.35% drop from the session before settling in for the closing price of $3.43. A 52-week range for VYGR has been $2.64 – $9.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 1.48% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -74.92%. With a float of $45.00 million, this company’s outstanding shares have now reached $55.21 million.
In an organization with 172 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 48.55%, operating margin of -152.03%, and the pretax margin is -125.46%.
Voyager Therapeutics Inc (VYGR) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Voyager Therapeutics Inc stocks. The insider ownership of Voyager Therapeutics Inc is 18.69%, while institutional ownership is 62.86%. The most recent insider transaction that took place on Apr 02 ’25, was worth 34,595. In this transaction Chief Medical Officer of this company sold 10,086 shares at a rate of $3.43, taking the stock ownership to the 157,914 shares. Before that another transaction happened on Apr 02 ’25, when Company’s President and CEO sold 10,885 for $3.43, making the entire transaction worth $37,336. This insider now owns 430,931 shares in total.
Voyager Therapeutics Inc (VYGR) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -74.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.46% during the next five years compared to 1.48% growth over the previous five years of trading.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
You can see what Voyager Therapeutics Inc (VYGR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.83 million. That was better than the volume of 0.48 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 46.95%.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 24.64%, which indicates a significant decrease from 27.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was lower than the 0.22 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.21, while its 200-day Moving Average is $4.74. However, in the short run, Voyager Therapeutics Inc’s stock first resistance to watch stands at $3.35. Second resistance stands at $3.62. The third major resistance level sits at $3.76. If the price goes on to break the first support level at $2.94, it is likely to go to the next support level at $2.80. Assuming the price breaks the second support level, the third support level stands at $2.53.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
There are 55,336K outstanding shares of the company, which has a market capitalization of 170.16 million. As of now, sales total 80,000 K while income totals -65,000 K. Its latest quarter income was 6,470 K while its last quarter net income were -31,020 K.
